In Brief: Tavist-D caplets
This article was originally published in The Tan Sheet
Executive Summary
Tavist-D caplets: Novartis Consumer Health's clemastine fumurate/phenylpropanolamine product approved for the common cold in extended release caplet form Oct. 17. The supplemental application for caplets (NDA 20-640) was filed by the company May 22. Tavist-D capsules and tablets were approved for the cold indication on Oct. 31, 1996 ("The Tan Sheet" Nov. 4, 1996, In Brief)...